Renovaro Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Renovaro Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Renovaro Biosciences Inc
Rating: 0.80125
Author: Trendlyne DVM scores

about

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

0.27 -0.01 (-3.57%)

Near 52W Low of $0.26

1.2M

XNAS Volume

XNAS 31 Jul, 2025 12:14 PM (EDT)

Board Meeting

The board meeting for Renovaro Biosciences Inc is scheduled for today, for the purpose of Renovaro Inc Annual General Meeting for 2024 See details

Not Eligible

Expensive Valuation

14.5 / 100

Technically Bearish

17.6 / 100

No estimates available

Renovaro Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Renovaro Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Near 52W Low of $0.26

SWOT Analysis

Renovaro Biosciences Inc Live Price Chart